Stockscreener 앱 받기
8.83
1.23%
-0.11
전일 마감가:
$8.94
열려 있는:
$8.95
하루 거래량:
60,798
Relative Volume:
0.54
시가총액:
$82.54M
수익:
$24.99M
순이익/손실:
$-108.83M
주가수익비율:
-0.5875
EPS:
-15.0286
순현금흐름:
$-91.62M
1주 성능:
-1.89%
1개월 성능:
+20.79%
6개월 성능:
+9.96%
1년 성능:
-25.40%
1일 변동 폭
$8.675
$8.98
1주일 범위
$8.49
$9.42
52주 변동 폭
$6.01
$17.44
Adicet Bio Inc Stock (ACET) Company Profile
명칭
Adicet Bio Inc
전화
617-482-2333
주소
131 DARTMOUTH STREET, BOSTON
Compare ACET vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACET
Adicet Bio Inc
|
8.83 | 82.54M | 24.99M | -108.83M | -91.62M | -15.03 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-30 | 재개 | Guggenheim | Buy |
| 2024-09-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-06-27 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-06-27 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-06-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-09-21 | 개시 | JP Morgan | Overweight |
| 2022-03-31 | 개시 | SMBC Nikko | Outperform |
| 2022-03-08 | 개시 | Truist | Buy |
| 2022-03-04 | 개시 | Jefferies | Buy |
| 2021-05-18 | 개시 | BTIG Research | Buy |
| 2021-04-23 | 개시 | H.C. Wainwright | Buy |
| 2021-04-14 | 개시 | Canaccord Genuity | Buy |
| 2021-04-08 | 개시 | Guggenheim | Buy |
| 2020-11-04 | 개시 | B. Riley Securities | Buy |
| 2020-10-27 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-16 | 개시 | Wedbush | Outperform |
모두보기
Adicet Bio Inc 주식(ACET)의 최신 뉴스
Price to earnings forward of Adicet Bio, Inc. – NASDAQ:ACET - TradingView
Enterprise value to revenue forward of Adicet Bio, Inc. – NASDAQ:ACET - TradingView
Adicet Bio (ACET) Proxy filing Summary - Quartr
Are medical stocks lagging Adicet Bio (ACET) this year? - MSN
Adicet Bio Inc (ACET) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell Microcap Value Benchmark Index - marketscreener.com
Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell Microcap Index - marketscreener.com
Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell 3000E Index - marketscreener.com
ACET Q1 2026 Earnings: Smaller-Than-Expected Loss Drives Shares HigherEarnings Cycle Outlook - dars.gov.et
1IJ Forecast — Price Target — Prediction for 2027 - TradingView
Adicet Bio Inc (ACET) Valuation: PE, PB & Fair Value Analysis - TradingKey
Adicet Bio Inc Actuals & Estimates (MUN:1IJ) - TradingView
ACET Forecast — Price Target — Prediction for 2027 - TradingView
Adicet Bio Inc Actuals & Estimates (TRADEGATE:1IJ) - TradingView
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Form 4 Adicet Bio Inc For: 23 June By Investing.com - Investing.com Nigeria
Adicet Bio (ACET) CEO Chen Schor receives 55,000 stock options at $8.10 - Stock Titan
Adicet Bio (ACET) grants CSO Blake Aftab 55,000 stock options - Stock Titan
Director at Adicet Bio (NASDAQ: ACET) receives 4,200 stock options grant - Stock Titan
Director at Adicet Bio (ACET) awarded 4,200 options at $8.10 strike - Stock Titan
Adicet Bio (ACET) director receives stock options for 4,200 shares at $8.10 - Stock Titan
Adicet Bio (ACET) director receives 4,200 stock options at $8.10 strike - Stock Titan
Director Katie Peng receives 4,200 Adicet Bio (ACET) stock options at $8.10 - Stock Titan
Director at Adicet Bio (ACET) receives 4,200 stock options award - Stock Titan
ACET Q1 2026 Earnings: EPS Beats Estimates by 40.7% as Clinical Progress ContinuesEBITDA Analysis - dars.gov.et
Adicet Bio Stockholders Back Directors, Pay and Auditor - TipRanks
Adicet Bio (ACET) investors back board nominees, pay and KPMG at 2026 meeting - Stock Titan
Adicet Bio Inc (ACET) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Adicet Bio Inc (ACET) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Adicet Bio Inc (ACET) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Adicet Bio Inc (ACET) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Adicet Bio Inc (ACET) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Adicet Bio Inc (ACET) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Adicet Bio Inc (ACET) Institutional Confidence - TradingKey
ACET: All proposals, including director elections and auditor ratification, were approved by stockholders - TradingView
10 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Adicet Bio Inc. (ACET) Q1 2026 Earnings: Narrowed Loss Beats Street on Cost Discipline, Pipeline ProgressEBITDA Estimate Trend - newsline.com
Adicet Bio teases autoimmune data catalysts, PSMA plans at Jefferies conference - MSN
ACET Q1 2026 Earnings: Better-than-Expected Losses Lift SharesAdjusted Earnings Analysis - newsline.com
Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsight - GlobeNewswire Inc.
BPAS - FinancialContent
Adicet Bio Teases Autoimmune Data Catalysts, PSMA Plans at Jefferies Conference - sharewise.com
Adicet Bio (ACET) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Adicet Bio (ACET) Slips Nearly 6% as Shares Test Key Support LevelsLong Short Pair - newsline.com
Adicet Bio Inc. (ACET) Surges 7.75% as Bullish Momentum BuildsDividend Arbitrage - The Legal Advocate
ACETAdicet Bio Inc Options - Finviz
Adicet Bio Inc (ACET) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
자본화:
|
볼륨(24시간):